EyeGate Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- EyeGate Pharmaceuticals's estimated annual revenue is currently $1.8M per year.
- EyeGate Pharmaceuticals's estimated revenue per employee is $100,500
- EyeGate Pharmaceuticals's total funding is $82.4M.
Employee Data
- EyeGate Pharmaceuticals has 18 Employees.
- EyeGate Pharmaceuticals grew their employee count by 6% last year.
EyeGate Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Managing Director | Reveal Email/Phone |
2 | Chief Development Officer | Reveal Email/Phone |
3 | President and CEO | Reveal Email/Phone |
EyeGate Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is EyeGate Pharmaceuticals?
Based in Waltham Massachusetts, EyeGate Pharma is developing a proprietary platform of medicines to treat diseases of the eye using its unique, non-invasive, iontophoretic drug-delivery system called EyeGate® II. This proprietary technology platform is based on over 10-years of development at the Bascom Palmer Eye Institute at the University of Miami and has been tested extensively in both preclinical and human studies in Europe. Because of the human eye's special anatomy, effective delivery of medicines to treat chronic disease or diseases in the mid and posterior segments of the eye is less than adequate. We believe the EyeGate® II Delivery System will offer both physicians and patients an important new alternative in advancing the treatment of eye disease.
keywords:N/A
$82.4M
Total Funding
18
Number of Employees
$1.8M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EyeGate Pharmaceuticals News
... Novartis AG, Valeant Pharmaceuticals International Inc., Alimera Sciences Inc., Akorn Inc., Abbvie Inc., Eyegate Pharmaceuticals Inc.,...
Similarly, in October 2019, Sun Pharmaceutical Industries launched the ophthalmic ... Inc.; EYEGATE PHARMACEUTICALS, INC. among others.
Santen Pharmaceutical; Eyegate Pharmaceuticals; Alimera Sciences; And More. Global Uveitis Treatment Market Segmentation: By Product Type:.
EyeGate Pharma, a Waltham, MA-based pharmaceutical company developing ocular therapeutics, has raised an additional $5.9m as part of its Series D financing round. With this additional close, Eyegate has raised a total of $28.5m in Series D funding to date. The funds will be used to continue de ...
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.6M | 18 | -5% | N/A |
#2 | $1.6M | 18 | N/A | N/A |
#3 | $1.4M | 18 | -65% | $23.5M |
#4 | $3.5M | 18 | -10% | $19.5M |
#5 | $2.8M | 18 | 13% | N/A |